Last week, a Texas judge handed down a ruling that could reverse FDA approval of the abortion pill mifepristone.
Medication abortions account for over half of abortions in our country as well as being a critical drug for the treatment of many miscarriages. If it’s taken off the market, it could cause longer wait times at clinics and costlier logistics for patients.
That’s why this decision is so clearly not about women’s health and safety. In fact, it shows complete disregard for scientific evidence and the FDA’s authority. (Mifepristone has been FDA-approved for decades.)
Though decided in Texas, this decision has nationwide repercussions. It undermines the strong reproductive freedom protections we have here in New Jersey.
|